Vivos Therapeutics market cap VVOS
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Nov 2, 2026
- $2.2M
- Highest close in our data
- $173.9M
- Apr 2021
Vivos Therapeutics is worth $2.2M at the close on Nov 2, 2026, at $0.11 a share.
That is down 89% over the last year and down 98% over five years.
Its highest close in our data was $173.9M in Apr 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2.2M | $2.2M | $22.7M | −88% |
| 2025 | $18.2M | $12.4M | $40.2M | −19% |
| 2024 | $22.5M | $5.4M | $24.1M | +51% |
| 2023 | $14.9M | $3.3M | $40.3M | +61% |
| 2022 | $9.3M | $8.2M | $75.5M | −82% |
| 2021 | $51.8M | $51.8M | $173.9M | n/a |
Against its peers
Companies in Healthcare nearest Vivos Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| VVOSVivos Therapeutics | $2.2M |
| OXBROXBRIDGE RE HOLDINGS | $6.5M |
| EDUCEducational Development | $8.9M |
| GTIMGood Times Restaurants | $14M |
| MDRRMedalist Diversified | $17.9M |
| VIPVulcan Infrastructure & Power | $18.4M |
| BCGBinah Capital | $18.6M |
| MXCMexco Energy | $19.2M |
| ATCHAtlasClear | $20.6M |
| Peer median | $18.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Vivos Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.